Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)

The “Other” Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo -Inositol Chemistry)

(2015) Mark P. Thomas et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome

(2014) Simona Dinicola et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Cardiometabolic Aspects of the Polycystic Ovary Syndrome

(2012) Harpal S. Randeva et al.   ENDOCRINE REVIEWS

The effects of old, new and emerging medicines on metabolic aberrations in PCOS

(2012) Alexandra Bargiota et al.   Therapeutic Advances in Endocrinology and Metabolism

The Adapter Protein APPL1 Links FSH Receptor to Inositol 1,4,5-Trisphosphate Production and Is Implicated in Intracellular Ca2+Mobilization

(2011) Richard M. Thomas et al.   ENDOCRINOLOGY

Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome

(2011) Åsa Nybacka et al.   FERTILITY AND STERILITY

Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review

(2009) Stefano Palomba et al.   ENDOCRINE REVIEWS

Contribution of myo-inositol to reproduction

(2009) E. Papaleo et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Insulin and hyperandrogenism in women with polycystic ovary syndrome

(2009) Catherine G. Baptiste et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Evidence of proatherogenic inflammation in polycystic ovary syndrome

(2009) Frank González et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

(2008) Evanthia Diamanti-Kandarakis   EXPERT REVIEWS IN MOLECULAR MEDICINE